MassIVE MSV000100089

Partial Public

A degradomic landscape of proteolytic remodeling in melanoma lung metastasis

Description

Melanoma metastasis involves extensive remodeling of the tumor microenvironment, yet the proteolytic processes underlying pulmonary colonization remain poorly defined. Using the B16F10 intravenous melanoma model in C57BL/6J mice, we performed an integrative degradomic analysis of metastatic lung tissue, plasma, and the secretome of early-passaged primary cultures derived from metastatic foci. Semi-specific database searches identified nearly 8,000 semi-tryptic peptides across compartments, with the secretome exhibiting the highest burden of cleavage events, indicative of an intensely proteolytic microenvironment. Cleavage profiles were compartment-specific, dominated by actin in metastatic lung tissue, a2-macroglobulin in plasma, and SPARC in the secretome. Cleavage-site motif analysis revealed conserved His/Ser (P1/P1 prime) preferences in tissue and plasma, whereas the secretome showed a distinct Leu/Ser pattern. Discriminant-feature analysis uncovered unique proteolytic signatures for each compartment, and peptide-level mapping implicated at least 12 proteases (including MMP2, cathepsin D, and cathepsin E) as major contributors to metastatic niche remodeling. Functional enrichment demonstrated coordinated impacts on extracellular matrix organization, inflammation, and metabolic adaptation. These results define a compartment-resolved degradomic landscape of melanoma lung metastasis, highlight proteases driving metastatic remodeling, and provide cleavage signatures with potential value for biomarker discovery. [doi:10.25345/C5125QP6Z] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: melanoma ; protease ; proteolytic signaling ; biomarkers ; degradomics. ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order)
Andre Zelanis, Functional Proteomics Laboratory, Department of Science and Technology, Federal University of Sao Paulo, Sao Jose dos Campos, SP, Brazil, Brazil
Submitting User: azelanis
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.